Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 101

    1.

    Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

    Montero JA, Ruiz-Moreno JM.

    Br J Ophthalmol. 2007 Feb;91(2):131-3. No abstract available. PMID: 17244656 [PubMed - indexed for MEDLINE]Related articles

    2.

    Combined photodynamic therapy and intravitreal triamcinolone injection for the treatment of choroidal neovascularisation secondary to pathological myopia: a pilot study.

    Chan WM, Lai TY, Wong AL, Liu DT, Lam DS.

    Br J Ophthalmol. 2007 Feb;91(2):174-9. Epub 2006 Sep 20.PMID: 16987898 [PubMed - indexed for MEDLINE]Related articles

    3.

    Photodynamic therapy in combination with intravitreal triamcinolone for myopic choroidal neovascularization.

    Degenring RF, Jonas JB.

    Acta Ophthalmol Scand. 2005 Oct;83(5):621. No abstract available. PMID: 16188006 [PubMed - indexed for MEDLINE]Related articles

    4.

    Combined photodynamic therapy and intravitreal triamcinolone for the treatment of myopic choroidal neovascularization in a 13-year-old girl.

    Potter MJ, Szabo SM, Ho T.

    Graefes Arch Clin Exp Ophthalmol. 2006 May;244(5):639-41. Epub 2005 Sep 21.PMID: 16175378 [PubMed - indexed for MEDLINE]Related articles

    5.

    Combined photodynamic therapy and intravitreal triamcinolone acetonide for the treatment of myopic subfoveal choroidal neovascularization.

    Marticorena J, Gomez-Ulla F, Fernandez M, Pazos B, Rodriguez-Cid MJ, Sanchez-Salorio M.

    Am J Ophthalmol. 2006 Aug;142(2):335-7.PMID: 16876524 [PubMed - indexed for MEDLINE]Related articles

    6.

    Photodynamic therapy with verteporfin combined with intravitreal injection of triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2005 Feb;112(2):301-4.PMID: 15691567 [PubMed - indexed for MEDLINE]Related articles

    7.

    Combined photodynamic therapy and intravitreal triamcinolone for nonsubfoveal choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Retina. 2005 Sep;25(6):685-90.PMID: 16141854 [PubMed - indexed for MEDLINE]Related articles

    8.

    Verteporfin therapy combined with intravitreal triamcinolone in all types of choroidal neovascularization due to age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Ophthalmology. 2006 Jan;113(1):14-22. Epub 2005 Dec 19.PMID: 16360209 [PubMed - indexed for MEDLINE]Related articles

    10.

    Choroidal neovascularization in sorsby fundus dystrophy treated with photodynamic therapy and intravitreal triamcinolone acetonide.

    Peiretti E, Klancnik JM Jr, Spaide RF, Yannuzzi L.

    Retina. 2005 Apr-May;25(3):377-9. No abstract available. PMID: 15805922 [PubMed - indexed for MEDLINE]Related articles

    11.

    Combined photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide for choroidal neovascularization.

    Spaide RF, Sorenson J, Maranan L.

    Ophthalmology. 2003 Aug;110(8):1517-25.PMID: 12917166 [PubMed - indexed for MEDLINE]Related articles

    12.

    Triamcinolone acetonide as adjunctive treatment to verteporfin in neovascular age-related macular degeneration: a prospective randomized trial.

    Chaudhary V, Mao A, Hooper PL, Sheidow TG.

    Ophthalmology. 2007 Dec;114(12):2183-9.PMID: 18054638 [PubMed - indexed for MEDLINE]Related articles

    13.

    Photodynamic therapy with verteporfin for juxtafoveal choroidal neovascularisation secondary to pathological myopia.

    Gibson J.

    Eye (Lond). 2005 Aug;19(8):829-30. No abstract available. PMID: 16086038 [PubMed - indexed for MEDLINE]Related articles

    14.

    The temporal sequence of combined intravitreal triamcinolone acetonide and photodynamic therapy for exudative age-related macular degeneration.

    Roth DB, Kulkarni KM, Feuer WJ.

    Ophthalmic Surg Lasers Imaging. 2008 Jan-Feb;39(1):12-6.PMID: 18254345 [PubMed - indexed for MEDLINE]Related articles

    15.

    Photodynamic therapy with intravitreal triamcinolone in predominantly classic choroidal neovascularization: one-year results of a randomized study.

    Arias L, Garcia-Arumi J, Ramon JM, Badia M, Rubio M, Pujol O.

    Ophthalmology. 2006 Dec;113(12):2243-50. Epub 2006 Sep 25.PMID: 16996600 [PubMed - indexed for MEDLINE]Related articles

    16.

    Indocyanine green-mediated photothrombosis with intravitreal triamcinolone acetonide for subfoveal choroidal neovascularization in age-related macular degeneration.

    Arevalo JF, Garcia RA, Mendoza AJ.

    Graefes Arch Clin Exp Ophthalmol. 2005 Nov;243(11):1180-5. Epub 2005 May 20.PMID: 15906068 [PubMed - indexed for MEDLINE]Related articles

    17.

    The use of subretinal triamcinolone acetonide in the management of neovascular age-related macular degeneration: a pilot study.

    Kertes PJ, Coupland SG.

    Can J Ophthalmol. 2005 Oct;40(5):573-84.PMID: 16391620 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    Verteporfin and intravitreal triamcinolone acetonide combination therapy for occult choroidal neovascularization in age-related macular degeneration.

    Augustin AJ, Schmidt-Erfurth U.

    Am J Ophthalmol. 2006 Apr;141(4):638-45.PMID: 16564797 [PubMed - indexed for MEDLINE]Related articles

    20.

    Photodynamic therapy with verteporfin and intravitreal triamcinolone acetonide in the treatment of neovascular age-related macular degeneration.

    Ergun E, Maár N, Ansari-Shahrezaei S, Wimpissinger B, Krepler K, Wedrich A, Stur M.

    Am J Ophthalmol. 2006 Jul;142(1):10-16.PMID: 16815246 [PubMed - indexed for MEDLINE]Related articles

    Supplemental Content

    Find related data